SonoScape Medical Future Growth
Future criteria checks 5/6
SonoScape Medical is forecast to grow earnings and revenue by 31.1% and 22.7% per annum respectively. EPS is expected to grow by 31.4% per annum. Return on equity is forecast to be 17.1% in 3 years.
Key information
31.1%
Earnings growth rate
31.4%
EPS growth rate
Medical Equipment earnings growth | 23.8% |
Revenue growth rate | 22.7% |
Future return on equity | 17.1% |
Analyst coverage | Good |
Last updated | 16 Oct 2024 |
Recent future growth updates
Recent updates
Investors Appear Satisfied With SonoScape Medical Corp.'s (SZSE:300633) Prospects As Shares Rocket 28%
Oct 21These 4 Measures Indicate That SonoScape Medical (SZSE:300633) Is Using Debt Reasonably Well
Sep 20Weak Statutory Earnings May Not Tell The Whole Story For SonoScape Medical (SZSE:300633)
Sep 04Returns On Capital Signal Tricky Times Ahead For SonoScape Medical (SZSE:300633)
Aug 18Is SonoScape Medical Corp. (SZSE:300633) Expensive For A Reason? A Look At Its Intrinsic Value
Jul 17Does SonoScape Medical (SZSE:300633) Have A Healthy Balance Sheet?
Jun 13Pinning Down SonoScape Medical Corp.'s (SZSE:300633) P/E Is Difficult Right Now
May 22We Think SonoScape Medical (SZSE:300633) Can Manage Its Debt With Ease
Mar 12An Intrinsic Calculation For SonoScape Medical Corp. (SZSE:300633) Suggests It's 41% Undervalued
Feb 28Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,754 | 852 | 542 | 693 | 12 |
12/31/2025 | 3,087 | 681 | 439 | 783 | 12 |
12/31/2024 | 2,517 | 544 | 301 | 473 | 11 |
6/30/2024 | 2,090 | 352 | 151 | 354 | N/A |
3/31/2024 | 2,127 | 416 | 227 | 413 | N/A |
12/31/2023 | 2,120 | 454 | 312 | 489 | N/A |
9/30/2023 | 1,979 | 445 | 260 | 478 | N/A |
6/30/2023 | 1,970 | 468 | 273 | 474 | N/A |
3/31/2023 | 1,865 | 457 | 282 | 470 | N/A |
1/1/2023 | 1,763 | 370 | 283 | 473 | N/A |
9/30/2022 | 1,756 | 353 | 261 | 460 | N/A |
6/30/2022 | 1,637 | 313 | 177 | 375 | N/A |
3/31/2022 | 1,533 | 262 | 167 | 356 | N/A |
1/1/2022 | 1,445 | 247 | 151 | 303 | N/A |
9/30/2021 | 1,391 | 66 | 220 | 322 | N/A |
6/30/2021 | 1,320 | 38 | 287 | 374 | N/A |
3/31/2021 | 1,211 | -2 | 208 | 348 | N/A |
12/31/2020 | 1,163 | -46 | 116 | 271 | N/A |
9/30/2020 | 1,176 | 65 | 45 | 193 | N/A |
6/30/2020 | 1,195 | 54 | -30 | 141 | N/A |
3/31/2020 | 1,258 | 81 | 15 | 153 | N/A |
12/31/2019 | 1,254 | 102 | 32 | 190 | N/A |
9/30/2019 | 1,224 | 146 | 63 | 212 | N/A |
6/30/2019 | 1,231 | 207 | 90 | 220 | N/A |
3/31/2019 | 1,226 | 244 | 115 | 230 | N/A |
12/31/2018 | 1,227 | 253 | 153 | 234 | N/A |
9/30/2018 | 1,144 | 246 | -1 | 92 | N/A |
6/30/2018 | 1,106 | 234 | 55 | 129 | N/A |
3/31/2018 | 1,060 | 201 | N/A | 99 | N/A |
12/31/2017 | 989 | 190 | N/A | 139 | N/A |
9/30/2017 | 963 | 192 | N/A | 175 | N/A |
6/30/2017 | 885 | 171 | N/A | 146 | N/A |
3/31/2017 | 784 | 134 | N/A | 157 | N/A |
12/31/2016 | 719 | 130 | N/A | 137 | N/A |
3/31/2016 | 650 | 103 | N/A | 94 | N/A |
12/31/2015 | 686 | 106 | N/A | 56 | N/A |
12/31/2014 | 640 | 132 | N/A | 114 | N/A |
12/31/2013 | 592 | 71 | N/A | 90 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300633's forecast earnings growth (31.1% per year) is above the savings rate (2.9%).
Earnings vs Market: 300633's earnings (31.1% per year) are forecast to grow faster than the CN market (23.7% per year).
High Growth Earnings: 300633's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300633's revenue (22.7% per year) is forecast to grow faster than the CN market (13.5% per year).
High Growth Revenue: 300633's revenue (22.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300633's Return on Equity is forecast to be low in 3 years time (17.1%).